Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07374718
Eligibility Criteria:
Inclusion Criteria:
* Aged ≥ 18 years old
* ACS patients with high bleeding risk (meeting the ARC-HBR criteria)
* Moderate-to-high ischemic risk (OPT-CAD score ≥ 90)
* Predicted by the investigator to be able to tolerate 12 months of DAPT
* Voluntarily participate and sign the informed consent form, and be willing to receive the designated follow-up of this trial at specific time points
* Coronary artery lesions are primary and in-situ coronary artery lesions
* Target lesion diameter stenosis ≥ 70% or ≥ 50% (visual estimation) accompanied by evidence of myocardial ischemia
Exclusion Criteria:
* Patients with known allergy or contraindication to P2Y12 inhibitors, aspirin, or contrast agents
* Patients planning to undergo surgical intervention within 12 months
* Left Ventricular Ejection Fraction (LVEF) \< 35%
* Patients with contraindications to PCI
* Patients with a history of substance abuse (alcohol, cocaine, heroin, etc.), or with an expected life expectancy of less than 1 year
* Subjects with poor compliance or judged by the investigator to be unsuitable for participating in the study
* Female patients who are planning to be pregnant or are pregnant/lactating, and male patients planning to impregnate
* Chronic total occlusion lesions
* Lesions involving the left main coronary artery
* Severe calcified and tortuous lesions
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07374718
Study Brief:
Protocol Section:
NCT07374718